Margaret Corrigan
Overview
Explore the profile of Margaret Corrigan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wetten A, Ogle L, Mells G, Hegade V, Jopson L, Corrigan M, et al.
Can J Gastroenterol Hepatol
. 2022 Dec;
2022:3618090.
PMID: 36523650
Background And Aims: A third of patients with primary biliary cholangitis (PBC) experience poorly understood cognitive symptoms, with a significant impact on quality of life (QOL), and no effective medical...
2.
Macken L, Corrigan M, Prentice W, Finlay F, McDonagh J, Rajoriya N, et al.
Frontline Gastroenterol
. 2022 Jul;
13(e1):e116-e125.
PMID: 35812034
Palliative care remains suboptimal in advanced cirrhosis, in part relating to a lack of evidence-based interventions. Ascites remains the most common cirrhosis complication resulting in hospitalisation. Many patients with refractory...
3.
Corrigan M, Thomas R, McDonagh J, Speakman J, Abbas N, Bardell S, et al.
Frontline Gastroenterol
. 2021 Feb;
12(2):108-112.
PMID: 33613941
Objective: Refractory ascites is an established indication for liver transplantation. While transplantation is regarded as the definitive therapy for this condition, many patients are unsuitable due to comorbidity or frailty....
4.
Chen Y, Arndtz K, Webb G, Corrigan M, Akiror S, Liaskou E, et al.
JHEP Rep
. 2020 Feb;
1(5):369-376.
PMID: 32039388
Background & Aims: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by progressive inflammatory and fibrotic injury to the biliary tree. We sought to further delineate the...
5.
Corrigan M, Haydon G, Thompson F, Rajoriya N, Peplow C, Hubscher S, et al.
JHEP Rep
. 2020 Feb;
1(1):66-69.
PMID: 32039353
No abstract available.
6.
Corrigan M, Hirschfield G, Greenfield S, Parry J
BMJ Open Gastroenterol
. 2019 Jul;
6(1):e000226.
PMID: 31321066
Patients with primary biliary cholangitis (PBC) can be stratified into low-risk and high-risk groups based on their response to treatment. Newly published guidelines from the British Society of Gastroenterology suggest...
7.
Hegade V, Pechlivanis A, McDonald J, Rees D, Corrigan M, Hirschfield G, et al.
Liver Int
. 2019 Feb;
39(5):967-975.
PMID: 30735608
Background And Aims: Pruritus is a common symptom in patients with primary biliary cholangitis (PBC) for which ileal bile acid transporter (IBAT) inhibition is emerging as a potential therapy. We...
8.
Jopson L, Khanna A, Peterson P, Rudell E, Corrigan M, Jones D
Dig Dis Sci
. 2018 May;
63(10):2547-2554.
PMID: 29736833
Background: Primary Biliary Cholangitis (PBC, formerly cirrhosis), is a chronic cholestatic liver disease which until spring 2016 had a single licensed therapy, Ursodeoxycholic acid (UDCA). Approximately 30% of patients do...
9.
Corrigan M, Hirschfield G
Frontline Gastroenterol
. 2017 Aug;
7(4):240-245.
PMID: 28839864
The three classic autoimmune liver diseases are recognised based on identifying varying clinical, laboratory, histological and radiological features that collectively classify patients. In the absence of defined aetiological factors, it...
10.
Arndtz K, Corrigan M, Rowe A, Kirkham A, Barton D, Fox R, et al.
BMJ Open
. 2017 Jul;
7(6):e015081.
PMID: 28674140
Introduction: Primary sclerosing cholangitis (PSC) is a progressive inflammatory liver disease characterised by relentless liver fibrosis and a high unmet need for new therapies. Preventing fibrosis represents an important area...